|
Index of reports
> Cases resulting in death (7)
> Cases with Myelodysplastic Syndrome (2)
Below is the selection of adverse event reports related to Synthroid (Levothyroxine) that includes cases resulting in death where reactions include myelodysplastic syndrome.
Adverse event in 90 year old male receiving Synthroid (Levothyroxine)
Reported by a physician from United States on 2007-10-29
Patient: 90 year old male
Adverse reactions / side effects: Haemoglobin Decreased, Myelodysplastic Syndrome, Platelet Count Decreased, Renal Failure Chronic, Disease Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Revlimid
Dosage: 5 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2007-04-20
End date: 2007-06-08
Synthroid
Dosage: qd
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Aranesp; Coreg; Lasix
Adverse event in 90 year old male receiving Synthroid (Levothyroxine)
Reported by a physician from United States on 2007-10-16
Patient: 90 year old male
Adverse reactions / side effects: Haemoglobin Decreased, Myelodysplastic Syndrome, Platelet Count Decreased, Disease Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Revlimid
Dosage: 5 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2007-04-20
End date: 2007-06-08
Synthroid
Dosage: qd
Indication: Drug USE FOR Unknown Indication
End date: 2007-07-13
Other drugs received by patient: Aranesp; Coreg; Lasix
|
